Clinical Evaluation of the Safety and Performance of Microwave Coagulation Using the HS1 Instrument

Clinical Evaluation of the Safety and Performance of Microwave Coagulation Using the HS1 Instrument for Actual or Potential Non-variceal Bleeding in the Upper Gastrointestinal (GI) Tract

Clinical evaluation of the safety and performance of microwave coagulation using the HS1 Instrument for actual or potential non-variceal bleeding in the upper Gastrointestinal (GI) tract

Inclusion Criteria:

• Patient or authorised representative able to comprehend and sign the Informed Consent form.
• Actual or potential non-variceal bleeding in the upper GI, including angiodysplasia or AVM malformations such as Dieulafoy's lesion with a Glasgow-Blatchford score of greater than 1

Exclusion Criteria:

• As stated in the contraindications in the HS1 IFU;
• Aged <18 years of age
• Those described as vulnerable populations in EN ISO 14155;
• Patients with a known coagulopathy (congenital);
• Concurrent participation in another experimental intervention or drug study
• Unwilling or unable to provide informed consent.
• A patient whose Glasgow-Blatchford score is 1 or less